About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
FDA Grants Accelerated Approval for Pembrolizumab in Relapsed/Refractory PMBCL
By
Loretta Nastoupil
18 Videos
613 views
June 29, 2018
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Related Content
AUTOPLAY
ON
08:18
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…
Feat.
A. Zhou
09:27
ASH 2022 Conference Coverage
MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…
Feat.
M. McMullin
17:21
Daniel Addison
Cardiovascular Considerations With (Contemporary) BTKi in the Treatm…
06:09
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Outcomes of Pts With Richter's Transfo…
Feat.
A. Kittai
16:25
Northwestern Medicine Oncology and Hematology
Diagnosis and Goals of Therapy in PV
Feat.
B. Stein
35:24
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: Aggressive B-Cell Lymphomas
Feat.
G. Nowakowski
10:49
Monia Marchetti
Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
04:34
ecancer
ASCO® 2023 Insights: "Observation Vs. Radiotherapy in Primary M…
Feat.
E. Zucca
15:28
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Treatment Options for Primary Mediastinal B-Cell Lymphoma
Feat.
K. Dunleavy
08:21
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "The Phase 2 KEYNOTE-B68 Trial - Efficacy …
Feat.
A. Mcdonald
18:10
SOHO Turkey 2023
SOHO Turkey 2023: DLBCL Management
Feat.
I. Barista
02:27
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Efficacy of Mosunetuzumab Monotherapy in Pa…
Feat.
C. Cheah
05:13
ASCO 2022 Conference Coverage
ASCO 2022 PACIFIC Trial Updates: Response Kinetics, Safety & Eff…
Feat.
R. Steiner
02:39
ecancer
ASCO® 2023 Insights: "ZUMA-7 Study Summary - Axi-Cel in Early R…
Feat.
J. Westin
05:45
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Anti-CD19 CAR T-Cell Therapy for Richter&#x…
Feat.
A. Kittai
25:46
SOHO Highlights: State of the Art and Next Questions
SOHO Highlights - State of the Art & Next Questions: Aggressive …
Feat.
L. Sehn
07:54
5th SOHO Italy Annual Conference
SOHO Italy 2023: Challenges in the Histopathological Diagnosis of No…
Feat.
S. Fratoni
15:35
2021 Virtual ESMO Review
ESMO 2021 Highlights on Lymphomas: R/R Marginal Zone Lymphoma, PMLBC…
Feat.
J. Vose
19:21
2021 Virtual ESMO Review
ESMO 2021 Hematologic Malignancies Panel Discussion
Feat.
J. Vose,
H. Erba
